Skip to main content
MANIFOLD
The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
36
Ṁ1kṀ2k
2029
14%
chance

https://www.wired.com/story/drugs-aging-medicine-biotech/

Jan 4, 1:44pm: The FDA will approve a drug for the treatment of senesense (aging) before the end of the decade (before 2030) → The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)

Get
Ṁ1,000
to start trading!
Sort by:

One distinction that matters for resolution: FDA's human side (CDER) has no aging indication, but FDA's veterinary side (CVM) already accepted lifespan extension as an indication for a dog drug in 2023 and accepted its safety package in January 2026. If this market means human approval, that's the relevant contrast; the dog approval is expected to be decided around 2027. I run both halves as separate questions: https://manifold.markets/w0lph/will-the-fda-conditionally-approve and https://manifold.markets/w0lph/will-the-fda-approve-any-drug-for-a

Old age is like a curse,
But soon we'll have a new verse.
A drug will keep us young and fine,
And help us cheat Father Time.

predictedNO

I believe it's spelled: senescence

@ian fixed.

For a cure, as opposed to treatment, and no mention of FDA approval: